Short report: Suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States

American Journal of Tropical Medicine and Hygiene

Volumn 82, Issue 5, 2010, Pages 919-921

  Monath, Thomas P ^a  

^a Kleiner Perkins Caufield & Byers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FUROSEMIDE; HEPARIN; HYPERTENSIVE FACTOR; MANNITOL; YELLOW FEVER VACCINE;

ADULT; AGED; ARTICLE; AUTOPSY; BLOOD CLOTTING DISORDER; CASE REPORT; CELL HYPERPLASIA; CLINICAL FEATURE; ELECTROCARDIOGRAM; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KUPFFER CELL; LABORATORY TEST; LIVER DISEASE; LIVER DYSFUNCTION; LIVER HISTOLOGY; MALE; MYALGIA; SHOCK; UNITED STATES; VACCINATION; VIROLOGY; YELLOW FEVER VACCINE ASSOCIATED VISCETROPIC ADVERSE EVENT; FATALITY; MULTIPLE ORGAN FAILURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; FATAL OUTCOME; FEMALE; HUMANS; MALE; MULTIPLE ORGAN FAILURE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNITED STATES; YELLOW FEVER VACCINE;

EID: 77952687072     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0001     Document Type: Article

References (12)

1. Theiler M, Smith HH, 1937.The use of yellow fever virus modified by in vitro cultivation for human immunization. J Exp Med 65: 787-800.
2. Monath TP, Nichols R, Archambault WT, Moore L, Marchesani R, Tian J, Shope RE, Thomas N, Schrader R, Furby D, Bedford P, 2002. Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. Am J Trop Med Hyg 66: 533-541.
3. Martin M, Tsai TF, Cropp CB, Chang G-J, Holmes DA, Tseng J, Shieh W-J, Zaki SR, Al-Sanouri I, Cutrona AF, Ray G, Weld LH, Cetron MS, 2001. Multisystemic illness in elderly recipients of yellow fever vaccine: report of four cases. Lancet 358: 98.
4. Vasconcelos PF, Luna EJ, Galler R, Silva LI, Coimbra TL, Barros VL, Monath TP, Rodigues SG, Laval C, Costa ZG, Vilela MF, Santos CL, Papaiordanou PM, Alves VA, Andrade LD, Sato HK, Rosa ES, Froguas GB, Lacava E, Almeida LM, Cruz AC, Rocco IM, Santos RT, Oliva OF, Brazilian Yellow Fever Vaccine Evaluation Group, 2001. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet 358: 91-97.
5. Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD, 2001. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 358: 121-122. (Pubitemid 32709852)
6. Hayes EB, 2007. Acute viscerotropic disease following vaccination against yellow fever. Trans R Soc Trop Med Hyg 101: 967-971. (Pubitemid 47317251)
7. Monath TP, Cetron M, Teuwen D, Yellow fever Plotkin S, Orenstein W, Offit P, eds. Vaccines. Fifth edition. Saunders Elsevier, 2008, 959-1055.
8. Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB, 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 6077-6082.
9. Pulendran B, Miller J, Querec TD, Akondy R, Moseley N, Laur O, Glidewell J, Monson N, Zhu T, Zhu H, Staprans S, Lee D, Brinton MA, Perelygin AA, Vellozzi C, Brachman P Jr, Lalor S, Teuwen D, Eidex RB, Cetron M, Priddy F, del Rio C, Altman J, Ahmed R, 2008. Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis 198: 500-507.
10. Barwick R; Eidex for the Yellow Fever Vaccine Safety Working Group., 2004. History of thymoma and yellow fever vaccination. Lancet 364: 936.
11. Engel AR, Vasconcelos PF, MacArthur MA, Barrett AD, 2004. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Vaccine 22: 1073-1078.
12. Whittembury A, Ramirez G, Hernández H, Ropero AM, Waterman S, Ticona M, Brinton M, Uchuya J, Gershman M, Toledo W, Staples E, Campos C, Martínez M, Chang GJ, Cabezas C, Lanciotti R, Zaki S, Montgomery JM, Monath T, Hayes E, 2009. Viscerotropic disease following yellow fever vaccination in Peru. Vaccine 27: 5974-5981. (Pubitemid 47317251)